Cargando…

Cardiovascular Health and Disease in the Context of COVID-19

First documented in China in early December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly and continues to test the strength of healthcare systems and public health programs all over the world. Underlying cardiovascular disease has been recognized as a r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umbrajkar, Sidhant, Stankowski, Rachel V., Rezkalla, Shereif, Kloner, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935632/ https://www.ncbi.nlm.nih.gov/pubmed/33738009 http://dx.doi.org/10.14740/cr1199

Ejemplares similares

Post-Acute Sequelae of SARS-COVID-2 Syndrome: Just the Beginning
por: Rezkalla, Shereif H., et al.
Publicado: (2021)

Viral myocarditis: 1917–2020: From the Influenza A to the COVID-19 pandemics
por: Rezkalla, Shereif H., et al.
Publicado: (2021)

Recreational Marijuana Use: Is it Safe for Your Patient?
por: Rezkalla, Shereif, et al.
Publicado: (2014)

Aspirin overutilization for the primary prevention of cardiovascular disease
por: VanWormer, Jeffrey J, et al.
Publicado: (2014)

Insights into Cardiovascular Defects and Cardiac Epigenome in the Context of COVID-19
por: Sarkar, Shreya, et al.
Publicado: (2022)

Imaging for Cardiovascular Complications of COVID-19: Cardiac Manifestations in Context
por: Crosier, Rebecca, et al.
Publicado: (2023)

Testosterone and the Cardiovascular System: A Comprehensive Review of the Clinical Literature
por: Oskui, Peyman Mesbah, et al.
Publicado: (2013)

Stunned and Hibernating Myocardium: Where Are We Nearly 4 Decades Later?
por: Kloner, Robert A.
Publicado: (2020)

Sexual function in hypertensive patients receiving treatment
por: Reffelmann, Thorsten, et al.
Publicado: (2006)

COVID-19 and cardiovascular diseases
por: Mai, Francesca, et al.
Publicado: (2020)

COVID-19 and cardiovascular diseases
por: Liu, Fan, et al.
Publicado: (2020)

Predictive and preventive strategies to advance the treatments of cardiovascular and cerebrovascular diseases: the Ukrainian context
por: Lushchyk, Ulyana B, et al.
Publicado: (2012)

Emerging risk factors for cardiovascular diseases: Indian context
por: Gupta, Sushil, et al.
Publicado: (2013)

Recent advances and developments in COVID‐19 in the context of allergic diseases
por: Ding, Mei, et al.
Publicado: (2021)

Public Health Aspects of COVID-19 Infection with Focus on Cardiovascular Diseases
por: Masic, Izet, et al.
Publicado: (2020)

Testosterone and the Cardiovascular System: A Comprehensive Review of the Basic Science Literature
por: Herring, Michael J., et al.
Publicado: (2013)

Community and Social Context: An Important Social Determinant of Cardiovascular Disease
por: Singh, Rahul, et al.
Publicado: (2021)

Impact of COVID-19 on Cardiovascular Disease
por: Vosko, Ivan, et al.
Publicado: (2023)

Beyond Reperfusion: Acute Ventricular Unloading and Cardioprotection During Myocardial Infarction
por: Curran, Jerry, et al.
Publicado: (2019)

The Impact of COVID-19 on the Social Determinants of Cardiovascular Health
por: Faghy, Mark A., et al.
Publicado: (2023)

Revival of the heterologous prime‐boost technique in COVID‐19: An outlook from the history of outbreaks
por: Siddiqui, Amna, et al.
Publicado: (2022)

Astaxanthin in Cardiovascular Health and Disease
por: Fassett, Robert G., et al.
Publicado: (2012)

Modified scoping review of the enablers and barriers to implementing primary health care in the COVID-19 context
por: Edelman, Alexandra, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

COVID-19, cardiovascular diseases and cardiac troponins
por: Kim, Chan W, et al.
Publicado: (2021)

Cardiovascular Disease Complicating COVID-19 in the Elderly
por: Dayaramani, Christopher, et al.
Publicado: (2021)

COVID-19 and Cardiovascular Diseases: Challenges and Solutions
por: Sharma, Prachi, et al.
Publicado: (2021)

Association between COVID-19 and cardiovascular disease
por: Srivastava, Kamna
Publicado: (2020)

Biomarkers Associated with Cardiovascular Disease in COVID-19
por: Kaufmann, Christoph C., et al.
Publicado: (2022)

Cardiovascular Complications Related to COVID-19 Disease
por: Alsatli, Raed A.
Publicado: (2020)

Digital Health Opportunities to Improve Primary Health Care in the Context of COVID-19: Scoping Review
por: Silva, Cícera Renata Diniz Vieira, et al.
Publicado: (2022)

Health Care Implications of the COVID-19 Pandemic for the Cardiovascular Practitioner
por: McAlister, Finlay A., et al.
Publicado: (2023)

Global Health Governance and Health Equity in the Context of COVID-19: A Scoping Review
por: Kheir-Mataria, Wafa Abu El, et al.
Publicado: (2022)

Dysgeusia: A review in the context of COVID-19
por: Thomas, Davis C., et al.
Publicado: (2022)

Cardiología
por: Kloner, Robert A.
Publicado: (1987)

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors
por: Al-Ameri, H, et al.
Publicado: (2009)

Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic
por: Galarza-Delgado, Dionicio A., et al.
Publicado: (2023)

Cardiovascular Diseases (CVDs) in COVID-19 Pandemic Era
por: Gerc, Vjekoslav, et al.
Publicado: (2020)

Periodontal Health and Disease in the Context of Systemic Diseases
por: Isola, Gaetano, et al.
Publicado: (2023)

Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era
por: Greco, S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eu3cga4qei33liaeb0cpvrhjba